##  [New analysis of Novartis' Entresto® data shows long-term benefits on heart failure readmissions and total cardiovascular deaths](/us-en/news/media-releases/new-analysis-novartis-entresto-data-shows-long-term-benefits-heart-failure-readmissions-and-total-cardiovascular-deaths-0 "New analysis of Novartis' Entresto® data shows long-term benefits on heart failure readmissions and total cardiovascular deaths") 

  Nov 15, 2016